iodine has been researched along with Parkinson Disease in 15 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective study including 19 Parkinson's disease and 12 multiple system atrophy patients was performed." | 1.72 | Cardiac sympathetic innervation in Parkinson's disease versus multiple system atrophy. ( Bösch, S; Djamshidian, A; Donnemiller, E; Eckhardt, C; Eschlböck, S; Fanciulli, A; Kiechl, S; Krismer, F; Mair, K; Metzler, B; Poewe, W; Raccagni, C; Scherfler, C; Seppi, K; Uprimny, C; Virgolini, I; Wenning, GK, 2022) |
| " In particular, the monitoring and optimization of levodopa dosage are critical to mitigate the onset of undesired fluctuations in the patients' physical and emotional conditions such as speech function, motor behavior, and mood stability." | 1.51 | Wearable Sweat Band for Noninvasive Levodopa Monitoring. ( Bariya, M; Fan, Z; Hettick, M; Hou, L; Javey, A; Ji, W; Liaw, TS; Lin, Y; Nyein, HYY; Tai, LC; Yuan, Z; Zhao, C; Zhao, J, 2019) |
| "Noninvasive biomarkers for Parkinson's disease (PD) are currently unavailable." | 1.43 | Serum Tyrosine-to-Phenylalanine Ratio is Low in Parkinson's Disease. ( Hirayama, M; Ohno, K; Tsuda, T; Tsunoda, M; Yamamoto, M, 2016) |
| "In patients with Parkinson's disease, dysfunction of sweating was classified into two types: one type involved the postganglionic fibres and the other involved the preganglionic fibres or the central nervous system." | 1.29 | Sweat function in Parkinson's disease. ( Mano, Y; Mayer, RF; Nakamuro, T; Takayanagi, T, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Eckhardt, C | 1 |
| Krismer, F | 1 |
| Donnemiller, E | 1 |
| Eschlböck, S | 1 |
| Fanciulli, A | 1 |
| Raccagni, C | 1 |
| Bösch, S | 1 |
| Mair, K | 1 |
| Scherfler, C | 1 |
| Djamshidian, A | 1 |
| Uprimny, C | 1 |
| Metzler, B | 1 |
| Seppi, K | 1 |
| Poewe, W | 1 |
| Kiechl, S | 1 |
| Virgolini, I | 1 |
| Wenning, GK | 1 |
| SCHWAB, RS | 1 |
| CHAPMAN, EM | 1 |
| ASK-UPMARK, E | 1 |
| Foster, HD | 1 |
| Fahn, S | 1 |
| Prasad, AL | 1 |
| Delesie, R | 1 |
| Bora, SS | 1 |
| Radichevich, I | 1 |
| Werner, SC | 1 |
| Curzon, G | 1 |
| Kantamaneni, BD | 1 |
| Trigwell, J | 1 |
| Yu, Z | 2 |
| Tang, D | 2 |
| Glasco, DL | 1 |
| Sheelam, A | 1 |
| Ho, NHB | 1 |
| Bell, JG | 1 |
| Nyein, HYY | 2 |
| Bariya, M | 2 |
| Tran, B | 1 |
| Ahn, CH | 1 |
| Brown, BJ | 1 |
| Ji, W | 2 |
| Davis, N | 1 |
| Javey, A | 2 |
| Tai, LC | 1 |
| Liaw, TS | 1 |
| Lin, Y | 1 |
| Hettick, M | 1 |
| Zhao, C | 1 |
| Zhao, J | 1 |
| Hou, L | 1 |
| Yuan, Z | 1 |
| Fan, Z | 1 |
| Tsunoda, M | 2 |
| Hirayama, M | 2 |
| Tsuda, T | 2 |
| Ohno, K | 2 |
| Yamamoto, M | 1 |
| Mano, Y | 1 |
| Nakamuro, T | 1 |
| Takayanagi, T | 1 |
| Mayer, RF | 1 |
| Kumazawa, K | 1 |
| Sobue, G | 1 |
| Mitsuma, T | 1 |
| Sugenoya, J | 1 |
| Ogawa, T | 1 |
1 trial available for iodine and Parkinson Disease
| Article | Year |
|---|---|
Artifactual elevation of PBI from an iodinated dye used to stain medicinal capsules pink.
Topics: Bipolar Disorder; Blood Proteins; Capsules; Carbonates; Chromatography, Paper; Clinical Trials as To | 1969 |
14 other studies available for iodine and Parkinson Disease
| Article | Year |
|---|---|
Cardiac sympathetic innervation in Parkinson's disease versus multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Humans; Iodine; Multiple System Atrophy; Parkinson Disease; Prospective Studi | 2022 |
The value of depressing with radioactive iodine the thyroid function of selected patients with Parkinson's disease.
Topics: Humans; Iodine; Iodine Radioisotopes; Mental Disorders; Parkinson Disease; Patient Selection; Thyroi | 1954 |
Hyperthyroidism and parkinsonism.
Topics: Humans; Hyperthyroidism; Iodides; Iodine; Parkinson Disease; Parkinsonian Disorders | 1959 |
Disease family trees: the possible roles of iodine in goitre, cretinism, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's and Parkinson's diseases and cancers of the thyroid, nervous system and skin.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Congenital Hypothyroidism; Goiter; Humans; Iodine; | 1987 |
A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain.
Topics: Antiparkinson Agents; Brain Chemistry; Carbon Isotopes; Chromatography, Ion Exchange; Cold Temperatu | 1972 |
A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients.
Topics: Chromatography, Ion Exchange; Dihydroxyphenylalanine; Ferricyanides; Hot Temperature; Humans; Iodine | 1972 |
Artificial Neural Network-Assisted Wearable Flexible Sweat Patch for Drug Management in Parkinson's Patients Based on Vacancy-Engineered Processing of g-C
Topics: Biosensing Techniques; Glucose; Humans; Levodopa; Parkinson Disease; Sweat; Wearable Electronic Devi | 2022 |
Artificial Neural Network-Assisted Wearable Flexible Sweat Patch for Drug Management in Parkinson's Patients Based on Vacancy-Engineered Processing of g-C
Topics: Biosensing Techniques; Glucose; Humans; Levodopa; Parkinson Disease; Sweat; Wearable Electronic Devi | 2022 |
Artificial Neural Network-Assisted Wearable Flexible Sweat Patch for Drug Management in Parkinson's Patients Based on Vacancy-Engineered Processing of g-C
Topics: Biosensing Techniques; Glucose; Humans; Levodopa; Parkinson Disease; Sweat; Wearable Electronic Devi | 2022 |
Artificial Neural Network-Assisted Wearable Flexible Sweat Patch for Drug Management in Parkinson's Patients Based on Vacancy-Engineered Processing of g-C
Topics: Biosensing Techniques; Glucose; Humans; Levodopa; Parkinson Disease; Sweat; Wearable Electronic Devi | 2022 |
Smartphone-based detection of levodopa in human sweat using 3D printed sensors.
Topics: Humans; Levodopa; Parkinson Disease; Printing, Three-Dimensional; Smartphone; Sweat | 2023 |
A wearable patch for continuous analysis of thermoregulatory sweat at rest.
Topics: Biosensing Techniques; Body Temperature Regulation; Human Body; Humans; Hydrogen-Ion Concentration; | 2021 |
Wearable Sweat Band for Noninvasive Levodopa Monitoring.
Topics: Drug Monitoring; Female; Humans; Levodopa; Parkinson Disease; Sweat; Wearable Electronic Devices | 2019 |
Noninvasive monitoring of plasma L-dopa concentrations using sweat samples in Parkinson's disease.
Topics: Blood Chemical Analysis; Humans; Levodopa; Parkinson Disease; Sweat | 2015 |
Serum Tyrosine-to-Phenylalanine Ratio is Low in Parkinson's Disease.
Topics: Aged; Biomarkers; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Parkinson | 2016 |
Sweat function in Parkinson's disease.
Topics: Aged; Axons; Ceruletide; Galvanic Skin Response; Humans; Parkinson Disease; Skin; Sweat; Sweat Gland | 1994 |
Impairment of calcitonin gene-related peptide-induced potentiation of cholinergic sweat secretion in patients with multiple system atrophy.
Topics: Autonomic Nervous System Diseases; Calcitonin Gene-Related Peptide; Cerebellar Diseases; Drug Combin | 1997 |